Clinical Trials Browser

Phase 1/2 × Waldenstrom Macroglobulinemia × bazlitoran × Clear all

NCT02092909 2019-09-10

8400-401

Phase 1/2 Terminated

31 enrolled 18 charts

Waldenstrom Macroglobulinemia

NCT02363439 2018-01-09

Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401

Phase 1/2 Completed

5 enrolled 4 charts

Waldenstrom Macroglobulinemia